[go: up one dir, main page]

NO954545D0 - Inklusjonskomplekser av taxol eller taxoter, eller taxus-ekstrakt dannet med syklodekstrin, samt fremstilling og anvendelse derav - Google Patents

Inklusjonskomplekser av taxol eller taxoter, eller taxus-ekstrakt dannet med syklodekstrin, samt fremstilling og anvendelse derav

Info

Publication number
NO954545D0
NO954545D0 NO954545A NO954545A NO954545D0 NO 954545 D0 NO954545 D0 NO 954545D0 NO 954545 A NO954545 A NO 954545A NO 954545 A NO954545 A NO 954545A NO 954545 D0 NO954545 D0 NO 954545D0
Authority
NO
Norway
Prior art keywords
taxol
cyclodextrin
preparation
taxotes
well
Prior art date
Application number
NO954545A
Other languages
English (en)
Other versions
NO954545L (no
Inventor
Lajos Szente
Joszef Szejili
Andrasne Vikmon
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO954545D0 publication Critical patent/NO954545D0/no
Publication of NO954545L publication Critical patent/NO954545L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO954545A 1993-05-12 1995-11-10 Inklusjonskomplekser av taxol eller taxoter, eller taxus-ekstrakt dannet med syklodekstrin, samt fremstilling og anvendelse derav NO954545L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9301373A HU213200B (en) 1993-05-12 1993-05-12 The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
PCT/HU1994/000012 WO1994026728A1 (en) 1993-05-12 1994-05-09 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use

Publications (2)

Publication Number Publication Date
NO954545D0 true NO954545D0 (no) 1995-11-10
NO954545L NO954545L (no) 1995-11-10

Family

ID=10983581

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954545A NO954545L (no) 1993-05-12 1995-11-10 Inklusjonskomplekser av taxol eller taxoter, eller taxus-ekstrakt dannet med syklodekstrin, samt fremstilling og anvendelse derav

Country Status (23)

Country Link
US (1) US6284746B1 (no)
EP (1) EP0698018B1 (no)
JP (1) JP3693341B2 (no)
CN (1) CN1123030A (no)
AT (1) ATE225340T1 (no)
AU (1) AU693101B2 (no)
BG (1) BG100207A (no)
BR (1) BR9406292A (no)
CA (1) CA2162716C (no)
CZ (1) CZ291495A3 (no)
DE (1) DE69431476T2 (no)
DK (1) DK0698018T3 (no)
ES (1) ES2184764T3 (no)
FI (1) FI955424A0 (no)
HU (1) HU213200B (no)
IL (1) IL109613A (no)
NO (1) NO954545L (no)
OA (1) OA10323A (no)
PL (1) PL311561A1 (no)
PT (1) PT698018E (no)
SK (1) SK140595A3 (no)
WO (1) WO1994026728A1 (no)
YU (1) YU26894A (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0835657T3 (da) 1992-11-27 2005-01-10 Mayne Pharma Usa Inc Stabil, injicerbar paclitaxelsammensætning
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
AU753519B2 (en) * 1998-02-05 2002-10-17 Novartis Ag Compositions containing organic compounds
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
TWI321054B (en) * 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
GB0127677D0 (en) * 2001-11-19 2002-01-09 Vianex S A Inclusion complex
US20040106199A1 (en) * 2002-12-02 2004-06-03 Eliseev Alexey V. Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media
CN100486645C (zh) * 2006-09-12 2009-05-13 南京师范大学 含有环糊精紫杉醇包合物的药物组合物及其制备方法
CN100411688C (zh) * 2006-09-12 2008-08-20 南京师范大学 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法
CN101278929B (zh) * 2007-04-02 2011-05-18 王效山 含有藤黄酸类化合物的药物及藤黄酸类化合物的包合物的制备方法
ES2310122B1 (es) * 2007-04-20 2009-10-30 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
ITMI20071321A1 (it) * 2007-07-04 2009-01-05 Sea Marconi Technologies Di Va Nanospugne a base di ciclodestrine come veicolo per farmaci antitumorali
CL2007003876A1 (es) * 2007-12-28 2008-03-07 Univ De Concepcion Y Lab Andro Complejo de inclusion que esta formado por disulfiram y ciclodextrina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de la dependencia de alcohol y cocaina.
DK2331092T3 (da) 2008-08-21 2014-05-19 Univ Johns Hopkins Fremgangsmåder og sammensætninger til indgivelse af 3-halopyruvat og associerede forbindelser til behandling af cancer
CA2936963A1 (en) * 2014-01-14 2015-07-23 The Johns Hopkins University Liposome compositions encapsulating modified cyclodextrin complexes and uses thereof
CN103920163B (zh) * 2014-03-14 2016-09-14 南京大学 一种紫杉醇复合物、制备方法及其应用
WO2017079563A1 (en) 2015-11-06 2017-05-11 The Johns Hopkins University Methods of treating liver fibrosis by administering 3-bromopyruvate
GB201715008D0 (en) * 2017-09-18 2017-11-01 Inst De Medicina Molecular Faculdade De Medicina Univ De Lisboa TRPV2 Antagonists
CN113456586B (zh) 2018-07-25 2022-06-10 比卡生物科技（广州）有限公司 一种注射用多西他赛组合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
JPS62120324A (ja) * 1985-11-20 1987-06-01 Nippon Junyaku Kk 有機物質の水溶化方法
JP2651567B2 (ja) * 1986-03-20 1997-09-10 花王株式会社 メチル化β−シクロデキストリン
IE62095B1 (en) * 1988-03-29 1994-12-14 Univ Florida Pharmaceutical formulations for parenteral use
JP2929108B2 (ja) * 1988-10-28 1999-08-03 株式会社資生堂 化粧料および粉末化粧料
IT1227626B (it) 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
JPH02200671A (ja) * 1989-01-30 1990-08-08 Agency Of Ind Science & Technol インドールを抽出分離する方法およびインドール包接分離用薬剤
JPH035438A (ja) * 1989-05-31 1991-01-11 Kaken Pharmaceut Co Ltd フルルビプロフェン包接化合物およびこの包接化合物を用いる消炎鎮痛剤
GB8920135D0 (en) * 1989-09-06 1989-10-18 Erba Carlo Spa Use of dehydrated cyclodextrins for improving drug dissolution
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
HU212730B (en) 1990-03-28 1996-10-28 Chinoin Gyogyszer Es Vegyeszet Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
KR927003645A (ko) * 1990-05-21 1992-12-18 후지다 히로미찌 씨클로덱스트린 유도체
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
JPH0753396A (ja) 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法および用途
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor

Also Published As

Publication number Publication date
FI955424L (fi) 1995-11-10
EP0698018A1 (en) 1996-02-28
CA2162716C (en) 2005-03-08
BG100207A (bg) 1996-05-31
AU693101B2 (en) 1998-06-25
AU7008194A (en) 1994-12-12
HUT68589A (en) 1995-06-28
CZ291495A3 (en) 1996-04-17
HU213200B (en) 1997-03-28
BR9406292A (pt) 1995-12-26
US6284746B1 (en) 2001-09-04
PL311561A1 (en) 1996-02-19
DE69431476T2 (de) 2003-06-18
HU9301373D0 (en) 1993-09-28
ES2184764T3 (es) 2003-04-16
CN1123030A (zh) 1996-05-22
ATE225340T1 (de) 2002-10-15
FI955424A7 (fi) 1995-11-10
CA2162716A1 (en) 1994-11-24
YU26894A (sh) 1997-05-28
SK140595A3 (en) 1996-10-02
IL109613A (en) 1997-09-30
JP3693341B2 (ja) 2005-09-07
FI955424A0 (fi) 1995-11-10
JPH08510232A (ja) 1996-10-29
PT698018E (pt) 2003-02-28
WO1994026728A1 (en) 1994-11-24
NO954545L (no) 1995-11-10
EP0698018B1 (en) 2002-10-02
OA10323A (en) 1997-10-07
DE69431476D1 (de) 2002-11-07
IL109613A0 (en) 1994-08-26
DK0698018T3 (da) 2003-02-10

Similar Documents

Publication Publication Date Title
NO954545D0 (no) Inklusjonskomplekser av taxol eller taxoter, eller taxus-ekstrakt dannet med syklodekstrin, samt fremstilling og anvendelse derav
MX9306924A (es) Composiciones antitumorales que contienen derivados de taxano.
BR9307401A (pt) Composi-{es de extrato da casca de carvalho composi-{es sint-ticas relacionadas e m-todo de usar as mesmas
NO964433D0 (no) Farmasöytiske preparater på basis av derivater av taxanklassen
ATE219061T1 (de) Huperzin a analoge verbindungen
JO1696B1 (en) Acetamide derivatives
DE69905878D1 (de) Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
DK0605753T3 (da) Cyclodextrin-inklusionskompleks af taxol, fremgangsmåde til fremstilling heraf og anvendelse heraf
AU2861389A (en) Disubstituted pyridines
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
DE69815100D1 (de) Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
ATE157010T1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
WO1988007367A3 (en) Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs
DE59305285D1 (de) Transdermales therapeutisches system mit pentylentetrazol als wirkstoff
ES2113647T3 (es) Composicion.
ATE127118T1 (de) 2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.
UA27023C2 (uk) Спосіб профілактики та лікуваhhя серцево-судиhhих захворюваhь